ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,051.97
      -0.27%
      US Tech 100
      21,183.20
      0.24%
      Dow Jones
      44,368.56
      -0.50%
      Brent Oil
      74.295
      -0.68%
      Bitcoin
      95,879.00
      -2.06%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Zymeworks Inc (ZYME) Quote

      Zymeworks Inc

      Zymeworks Inc (ZYME)

      NASDAQ
      14.30
      1.05
      (7.92%)
      Closed February 12 4:00PM
      Delayed by 15 minutes
      14.00
      -0.30
      ( -2.10% )
      Pre Market: 6:26AM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      14.00
      Bid
      14.20
      Ask
      15.91
      Volume
      466
      0.00 Day's Range 0.00
      7.97 52 Week Range 17.70
      Market Cap
      964.285M
      Previous Close
      14.30
      Open
      -
      Last Trade
      1
      @
      14.01
      Last Trade Time
      05:56:04
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      455,959
      Shares Outstanding
      68,877,526
      Dividend Yield
      -
      PE Ratio
      -8.30
      Earnings Per Share (EPS)
      -1.72
      Revenue
      76.01M
      Net Profit
      -118.67M

      About Zymeworks Inc

      Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of differentiat... Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of differentiated product candidates. Its lead clinical candidate, zanidatamab, is a novel Azymetric HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.zymeworks.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Zymeworks Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ZYME. The last closing price for Zymeworks was $14.30. Over the last year, Zymeworks shares have traded in a share price range of $ 7.97 to $ 17.70.

      Zymeworks currently has 68,877,526 shares outstanding. The market capitalization of Zymeworks is $984.95 million. Zymeworks has a price to earnings ratio (PE ratio) of -8.30.

      Ask ADVFN Intelligence (AI)

      ZYME Latest News

      More News

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      January 10 2025
      ZYME (7.92%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      January 08 2025
      ZYME (7.92%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      January 06 2025
      ZYME (7.92%)

      Form 144 - Report of proposed sale of securities
      Edgar (US Regulatory)
      January 06 2025
      ZYME (7.92%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      December 12 2024
      ZYME (7.92%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      December 12 2024
      ZYME (7.92%)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.99-6.6044029352914.9915.1412.821539327414.13081044CS
      4-0.63-4.3062200956914.6315.1412.821534612714.34636436CS
      12-0.8-5.4054054054114.817.0712.4345595914.05810811CS
      263.6935.790494665410.3117.79.99555192613.26092205CS
      522.5522.270742358111.4517.77.9759214011.39960022CS
      1567.62119.4357366776.3817.76.0156095789.80096369CS
      2607.62119.4357366776.3817.76.0156095789.80096369CS

      ZYME - Frequently Asked Questions (FAQ)

      What is the current Zymeworks share price?
      The current share price of Zymeworks is $ 14.00
      How many Zymeworks shares are in issue?
      Zymeworks has 68,877,526 shares in issue
      What is the market cap of Zymeworks?
      The market capitalisation of Zymeworks is USD 984.95M
      What is the 1 year trading range for Zymeworks share price?
      Zymeworks has traded in the range of $ 7.97 to $ 17.70 during the past year
      What is the PE ratio of Zymeworks?
      The price to earnings ratio of Zymeworks is -8.3
      What is the cash to sales ratio of Zymeworks?
      The cash to sales ratio of Zymeworks is 12.96
      What is the reporting currency for Zymeworks?
      Zymeworks reports financial results in USD
      What is the latest annual turnover for Zymeworks?
      The latest annual turnover of Zymeworks is USD 76.01M
      What is the latest annual profit for Zymeworks?
      The latest annual profit of Zymeworks is USD -118.67M
      What is the registered address of Zymeworks?
      The registered address for Zymeworks is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
      What is the Zymeworks website address?
      The website address for Zymeworks is www.zymeworks.com
      Which industry sector does Zymeworks operate in?
      Zymeworks operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      GSATGlobalstar Inc
      $ 21.85
      (5,362.50%)
      		1.29k
      FGMCFG Merger II Corporation
      $ 11.80
      (144.81%)
      		1
      PEVPhoenix Motor Inc
      $ 0.5485
      (117.57%)
      		56.07M
      KELYBKelly Services Inc
      $ 21.78
      (57.83%)
      		83
      AIRTAir T Inc
      $ 30.99
      (54.87%)
      		1
      ROEEA Series Trust Astoria US Equal Weight Quality Kings ETF
      $ 15.01
      (-52.21%)
      		8
      CEFAGlobal X S&P Catholic Values Developed Ex US ETF
      $ 19.01
      (-40.25%)
      		2
      CLDXCelldex Therapeutics Inc
      $ 13.32
      (-40.16%)
      		4
      KTCCKeyTronic Corporation
      $ 2.01
      (-38.15%)
      		1
      CHCIComstock Holding Companies Inc
      $ 5.01
      (-37.76%)
      		14
      PEVPhoenix Motor Inc
      $ 0.5485
      (117.57%)
      		56.07M
      PRPHProPhase Labs Inc
      $ 0.429
      (52.94%)
      		23.55M
      TIVCTivic Health Systems Inc
      $ 0.9664
      (38.06%)
      		17.02M
      MGOLMGO Global Inc
      $ 0.6329
      (38.70%)
      		16.55M
      CYNCYNGN Inc
      $ 0.1199
      (-20.07%)
      		14.55M

      Discussion

      View Full Feed
      JustJack JustJack 4 minutes ago
      You are a moderator also so if I did something wrong you would have removed my post, but you didn't. 

      Get Steve to come here and debate me. 

      He hates this board because he can't delete the truth like he can on the other boards. 
      AITX
      StockSeedGems2143 StockSeedGems2143 4 minutes ago
      Is Devon a real company ?
      GEGP
      WebSlinger WebSlinger 4 minutes ago
      There are only a little over 6 weeks left before silkworm eating time.....

      Mmm, Mmm, Good!

      https://i.ibb.co/nz6zQL7/DELETE-elderly-man-eating-siilkworm-001.jpg
      KBLB
      StayHumble StayHumble 4 minutes ago
      wow💹16 BILLION+Historic BUYS✅Lots of Xperts Here💹 https://ih.advfn.com/stock-market/USOTC/humbl-pk-HMBL/historical
      HMBL
      uranium-pinto-beans uranium-pinto-beans 4 minutes ago
      HOOD
      Robinhood price target raised to $75 from $54 at Piper Sandler
      Piper Sandler raised the firm's price target on Robinhood to $75 from $54 and keeps an Overweight rating on the shares. The firm notes Robinhood reported solid EPS beat and progress on product rollouts. Shares are t
      uranium-pinto-beans uranium-pinto-beans 4 minutes ago
      European stock markets are mostly higher, with the FTSE 100 a notable exception. U.K. GDP numbers looked better than expected, which undermined hopes of accelerated easing from the BoE and weighed on equities. The DAX is up 0.9%, the FTSE 100 down -0.5%, as bonds recover. The German 10-year rate is
      DAX WTI
      0210 0210 5 minutes ago
      say NAV $150m/1,189k o/s = $120-130/share TANH book values(?) 👌🥂😮🤔😉
      TANH
      tw0122 tw0122 5 minutes ago
      10k out ... Capital and Liquidity
      BENF
      JustJack JustJack 6 minutes ago
      New member or insider? We both know the answer Alexoops. 
      AITX
      floridaboy floridaboy 7 minutes ago
      Couple filings due SOON, once filed that yield sign will go bye-bye...
      SAPX
      Alexulf Alexulf 9 minutes ago
      Dear Just Jack, why so sarcastic and hostile to the new member of the board? No reason to get so worked up, each one has his opinion. Right or wrong is less important than behaving appropriately together. Share your opinion, but please, no sabotage. You are a moderator, you know the rules, right? No
      AITX
      StayHumble StayHumble 10 minutes ago
      💹Xplosive ShortFilm incoming✅$AMC Silver investments Golden💹wow!

      ".....fire.....fire works.......believe it...."'
      https://cdn.vox-cdn.com/uploads/chorus_asset/file/8687957/tenor.gif
      AMC
      PEACHMAN PEACHMAN 14 minutes ago
      It is key to have the ability to both read and absorb facts and financials of IFUS

      https://impactfusionbrands.com/

      IFUS STRONG
      IFUS
      MasterBlastr MasterBlastr 15 minutes ago
      Cool . . . GL. Came in 17th out of 200 last week so will try to keep it going.
      ITYS ITYS 16 minutes ago
      How many coffee shop interviews can Conman do? Be alot easier if MFB had real fire certifications?

      Conboy did same with ECOB, big boys caught him cheating certifications and bankrupt company. GEVI he is relying on a safer label award

      NO PROOF NO CERTIFCATION 5 YEARS OF
      GEVI
      Just the facts maam Just the facts maam 19 minutes ago
      LOL, Genentech (Roche subsidiary) gets an original new form of a drug approved and they announce it the next day.

      https://www.gene.com/media/press-releases/15052/2025-02-12/fda-approves-genentechs-evrysdi-tablet-a Genentech PR

      All I can say is, ANIP 's reason for wit
      ANIP
      ITYS ITYS 19 minutes ago
      Company JUST returned 45,000 PFD D that if converted would have been 450,000,000 ...the offering if ALL executed is .025 pps and 400m issued and raise 10m..

      I know some companies that are sling tons of Pfd C stock, raising millions at 3 x below the current PPS, MGON offering is higher
      GEVI MGON
      Stino2 Stino2 19 minutes ago
      Please Hi_Lo get a life and get a good job instead of telling bulshit here, please go away if you don't believe in this stock😪
      CIVX
      Alexulf Alexulf 21 minutes ago
      Yes, the revenue is growing :-) Have you seen the latest news and updates?

      https://radsecurity.us18.list-manage.com/trac...7eae867c17
      AITX
      TRAPPER JIM TRAPPER JIM 21 minutes ago
      Oh I can't wait till summer gets here. Next week we're going to have high temperatures in the low 20s. I'm really ready for some 80s. LOLOLOLOLOLOL 
      djjazzyjeff djjazzyjeff 21 minutes ago
      All good points I stand corrected
      CYDY
      glenn1919 glenn1919 22 minutes ago
      EFSH......PRPH.......UOKA........WISA........MULN..........................https://stockcharts.com/h-sc/ui?s=MULN&p=W&yr=1&mn=3&dy=0&id=p96837884856
      EFSH MULN PRPH
      powerwalker powerwalker 22 minutes ago
      Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update

      https://www.veronapharma.com/news/verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update/
      VRNA
      ArcherUnicorn98 ArcherUnicorn98 27 minutes ago
      Hi all, is this where people come to laugh at jps?
      FNMA

      Your Recent History

      NASDAQ
      ZYME
      Zymeworks
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads